These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 23996931)

  • 1. Occult progression by Apc-deficient intestinal crypts as a target for chemoprevention.
    Fischer JM; Schepers AG; Clevers H; Shibata D; Liskay RM
    Carcinogenesis; 2014 Jan; 35(1):237-46. PubMed ID: 23996931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MET Signaling Mediates Intestinal Crypt-Villus Development, Regeneration, and Adenoma Formation and Is Promoted by Stem Cell CD44 Isoforms.
    Joosten SPJ; Zeilstra J; van Andel H; Mijnals RC; Zaunbrecher J; Duivenvoorden AAM; van de Wetering M; Clevers H; Spaargaren M; Pals ST
    Gastroenterology; 2017 Oct; 153(4):1040-1053.e4. PubMed ID: 28716720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor.
    Lal G; Ash C; Hay K; Redston M; Kwong E; Hancock B; Mak T; Kargman S; Evans JF; Gallinger S
    Cancer Res; 2001 Aug; 61(16):6131-6. PubMed ID: 11507063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin receptor substrate-1 deficiency promotes apoptosis in the putative intestinal crypt stem cell region, limits Apcmin/+ tumors, and regulates Sox9.
    Ramocki NM; Wilkins HR; Magness ST; Simmons JG; Scull BP; Lee GH; McNaughton KK; Lund PK
    Endocrinology; 2008 Jan; 149(1):261-7. PubMed ID: 17916629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion of the WNT target and cancer stem cell marker CD44 in Apc(Min/+) mice attenuates intestinal tumorigenesis.
    Zeilstra J; Joosten SP; Dokter M; Verwiel E; Spaargaren M; Pals ST
    Cancer Res; 2008 May; 68(10):3655-61. PubMed ID: 18483247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of R-Spondin 1 in Apc
    Lähde M; Heino S; Högström J; Kaijalainen S; Anisimov A; Flanagan D; Kallio P; Leppänen VM; Ristimäki A; Ritvos O; Wu K; Tammela T; Hodder M; Sansom OJ; Alitalo K
    Gastroenterology; 2021 Jan; 160(1):245-259. PubMed ID: 32941878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RSPO3 expands intestinal stem cell and niche compartments and drives tumorigenesis.
    Hilkens J; Timmer NC; Boer M; Ikink GJ; Schewe M; Sacchetti A; Koppens MAJ; Song JY; Bakker ERM
    Gut; 2017 Jun; 66(6):1095-1105. PubMed ID: 27511199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Tcf4-GFP reporter mouse model for monitoring effects of Apc mutations during intestinal tumorigenesis.
    Boman B; Kopelovich L; Siracusa LD; Zhang T; Henderson K; Cofer Z; Buchberg AM; Fields JZ; Otevrel T
    Mol Carcinog; 2009 Sep; 48(9):821-31. PubMed ID: 19263440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutated K-ras(Asp12) promotes tumourigenesis in Apc(Min) mice more in the large than the small intestines, with synergistic effects between K-ras and Wnt pathways.
    Luo F; Brooks DG; Ye H; Hamoudi R; Poulogiannis G; Patek CE; Winton DJ; Arends MJ
    Int J Exp Pathol; 2009 Oct; 90(5):558-74. PubMed ID: 19765110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MSH2 deficiency contributes to accelerated APC-mediated intestinal tumorigenesis.
    Reitmair AH; Cai JC; Bjerknes M; Redston M; Cheng H; Pind MT; Hay K; Mitri A; Bapat BV; Mak TW; Gallinger S
    Cancer Res; 1996 Jul; 56(13):2922-6. PubMed ID: 8674041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temozolomide increases the number of mismatch repair-deficient intestinal crypts and accelerates tumorigenesis in a mouse model of Lynch syndrome.
    Wojciechowicz K; Cantelli E; Van Gerwen B; Plug M; Van Der Wal A; Delzenne-Goette E; Song JY; De Vries S; Dekker M; Te Riele H
    Gastroenterology; 2014 Nov; 147(5):1064-72.e5. PubMed ID: 25088490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BCL9-2 promotes early stages of intestinal tumor progression.
    Brembeck FH; Wiese M; Zatula N; Grigoryan T; Dai Y; Fritzmann J; Birchmeier W
    Gastroenterology; 2011 Oct; 141(4):1359-70, 1370.e1-3. PubMed ID: 21703997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of GDF-15 abolishes sulindac chemoprevention in the ApcMin/+ mouse model of intestinal cancer.
    Zimmers TA; Gutierrez JC; Koniaris LG
    J Cancer Res Clin Oncol; 2010 Apr; 136(4):571-6. PubMed ID: 19784846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Foxf2 in intestinal fibroblasts reduces numbers of Lgr5(+) stem cells and adenoma formation by inhibiting Wnt signaling.
    Nik AM; Reyahi A; Pontén F; Carlsson P
    Gastroenterology; 2013 May; 144(5):1001-11. PubMed ID: 23376422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor.
    Oshima M; Murai N; Kargman S; Arguello M; Luk P; Kwong E; Taketo MM; Evans JF
    Cancer Res; 2001 Feb; 61(4):1733-40. PubMed ID: 11245490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic mutations in intestinal adenomas regulate Bim-mediated apoptosis induced by TGF-β.
    Wiener Z; Band AM; Kallio P; Högström J; Hyvönen V; Kaijalainen S; Ritvos O; Haglund C; Kruuna O; Robine S; Louvard D; Ben-Neriah Y; Alitalo K
    Proc Natl Acad Sci U S A; 2014 May; 111(21):E2229-36. PubMed ID: 24825889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localized gene action controlling intestinal neoplasia in mice.
    Gould KA; Dove WF
    Proc Natl Acad Sci U S A; 1997 May; 94(11):5848-53. PubMed ID: 9159163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. APC mutation and the crypt cycle in murine and human intestine.
    Bjerknes M; Cheng H; Hay K; Gallinger S
    Am J Pathol; 1997 Mar; 150(3):833-9. PubMed ID: 9060821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene.
    Oshima M; Oshima H; Kitagawa K; Kobayashi M; Itakura C; Taketo M
    Proc Natl Acad Sci U S A; 1995 May; 92(10):4482-6. PubMed ID: 7753829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The absence of LPA receptor 2 reduces the tumorigenesis by ApcMin mutation in the intestine.
    Lin S; Lee SJ; Shim H; Chun J; Yun CC
    Am J Physiol Gastrointest Liver Physiol; 2010 Nov; 299(5):G1128-38. PubMed ID: 20724530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.